**Question:** A 45-year-old man is noted to have dilated cardiomyopathy with atrial fibrillation and a rapid ventricular rate. An agent is used to control the ventricular rate, but the cardiac contractility is also affected. What agent was most likely used?

**Core Concept:**
Dilated cardiomyopathy is a condition in which the heart muscle becomes weakened and enlarged, leading to impaired cardiac function. It can be associated with arrhythmias like atrial fibrillation and rapid ventricular rates. When using a drug to control ventricular rate in such cases, the choice should consider both rate control and contractility preservation.

**Why the Correct Answer is Right:**
The correct answer is **D:** Beta-blockers (e.g., metoprolol, bisoprolol), as they are the most suitable agents for rate control in atrial fibrillation patients with impaired cardiac contractility. Beta-blockers work by blocking beta-1 receptors in the heart, leading to decreased heart rate and reduced oxygen demand on the heart. Additionally, they can have some positive inotropic effect (improve cardiac contractility) due to their effects on calcium channels and adenyl cyclase system.

**Why Each Wrong Option is Incorrect:**
A. Calcium channel blockers (e.g., verapamil, diltiazem) are primarily used for rate control, not affecting cardiac contractility directly.
B. Antiarrhythmic agents (e.g., amiodarone, sotalol) are not preferred due to their potential to cause further contractility impairment and prolongation of the QT interval.
C. Digoxin is mainly used for heart failure management and can improve cardiac contractility, but it is not as effective for rate control as beta-blockers.

**Clinical Pearl:**
In patients with dilated cardiomyopathy and atrial fibrillation, beta-blockers are the first-line choice for rate control, ensuring rate control and preserving cardiac contractility. Careful monitoring of heart rate, blood pressure, and echocardiogram is essential to adjust the dosage and ensure optimal treatment.